276 related articles for article (PubMed ID: 34111032)
1. Monocyte metabolic transcriptional programs associate with resistance to tuberculin skin test/interferon-γ release assay conversion.
Simmons JD; Van PT; Stein CM; Chihota V; Ntshiqa T; Maenetje P; Peterson GJ; Reynolds A; Benchek P; Velen K; Fielding KL; Grant AD; Graustein AD; Nguyen FK; Seshadri C; Gottardo R; Mayanja-Kizza H; Wallis RS; Churchyard G; Boom WH; Hawn TR
J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34111032
[TBL] [Abstract][Full Text] [Related]
2. Monocyte Transcriptional Responses to Mycobacterium tuberculosis Associate with Resistance to Tuberculin Skin Test and Interferon Gamma Release Assay Conversion.
Simmons JD; Dill-McFarland KA; Stein CM; Van PT; Chihota V; Ntshiqa T; Maenetje P; Peterson GJ; Benchek P; Nsereko M; Velen K; Fielding KL; Grant AD; Gottardo R; Mayanja-Kizza H; Wallis RS; Churchyard G; Boom WH; Hawn TR
mSphere; 2022 Jun; 7(3):e0015922. PubMed ID: 35695527
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium tuberculosis -induced monocyte transcriptional responses associated with resistance to tuberculin skin test/interferon-γ release assay conversion in people with HIV.
Hong H; Dill-Mcfarland KA; Benson B; Simmons JD; Peterson GJ; Benchek P; Stein CM; Boom WH; Mayanja-Kizza H; Hawn TR
AIDS; 2023 Dec; 37(15):2287-2296. PubMed ID: 37696247
[TBL] [Abstract][Full Text] [Related]
4. Differentially expressed transcript isoforms associate with resistance to tuberculin skin test and interferon gamma release assay conversion.
Simmons JD; Segnitz RM; Dill-McFarland KA; Stein CM; Peterson GJ; Mayanja-Kizza H; Boom WH; Hawn TR
PLoS One; 2023; 18(4):e0284498. PubMed ID: 37058459
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterial-specific secretion of cytokines and chemokines in healthcare workers with apparent resistance to infection with
Shey MS; Balfour A; Masina N; Bekiswa A; Schutz C; Goliath R; Dielle R; Katoto PD; Wilkinson KA; Lewinsohn D; Lewinsohn DA; Meintjes G
Front Immunol; 2023; 14():1176615. PubMed ID: 37275871
[TBL] [Abstract][Full Text] [Related]
6. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
[TBL] [Abstract][Full Text] [Related]
7. IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure.
Lu LL; Smith MT; Yu KKQ; Luedemann C; Suscovich TJ; Grace PS; Cain A; Yu WH; McKitrick TR; Lauffenburger D; Cummings RD; Mayanja-Kizza H; Hawn TR; Boom WH; Stein CM; Fortune SM; Seshadri C; Alter G
Nat Med; 2019 Jun; 25(6):977-987. PubMed ID: 31110348
[TBL] [Abstract][Full Text] [Related]
8. Discordance between TST and QFT-TBGold Plus for Latent Tuberculosis Screening among Under-Five Children: An Interim Analysis.
Surve S; Bhor V; Naukariya K; Begum S; Munne K; Tipre P; Sutar N; Jaiswal A; Bhonde G; Chauhan S; Shah I
J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34904674
[TBL] [Abstract][Full Text] [Related]
9. Effect of Pregnancy on Interferon Gamma Release Assay and Tuberculin Skin Test Detection of Latent TB Infection Among HIV-Infected Women in a High Burden Setting.
LaCourse SM; Cranmer LM; Matemo D; Kinuthia J; Richardson BA; Horne DJ; John-Stewart G
J Acquir Immune Defic Syndr; 2017 May; 75(1):128-136. PubMed ID: 28141782
[TBL] [Abstract][Full Text] [Related]
10. Immunological characterization of latent tuberculosis infection in a low endemic country.
de Paus RA; van Meijgaarden KE; Prins C; Kamphorst MH; Arend SM; Ottenhoff THM; Joosten SA
Tuberculosis (Edinb); 2017 Sep; 106():62-72. PubMed ID: 28802407
[TBL] [Abstract][Full Text] [Related]
11. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
[TBL] [Abstract][Full Text] [Related]
12. Superiority of Interferon Gamma Assay Over Tuberculin Skin Test for Latent Tuberculosis in Inflammatory Bowel Disease Patients in Brazil.
Amorim RF; Viegas ERC; Carneiro AJV; Esberard BC; Chinem ES; Correa RS; Rodrigues L; Ribeiro-Alves M; Silva KS; de Souza HS; Carvalho ATP
Dig Dis Sci; 2019 Jul; 64(7):1916-1922. PubMed ID: 30673986
[TBL] [Abstract][Full Text] [Related]
13. Screening of latent tuberculosis infection among health care workers working in Hajj pilgrimage area in Saudi Arabia, using interferon gamma release assay and tuberculin skin test.
Bukhary ZA; Amer SM; Emara MM; Abdalla ME; Ali SA
Ann Saudi Med; 2018; 38(2):90-96. PubMed ID: 29620541
[TBL] [Abstract][Full Text] [Related]
14. An observational study identifying highly tuberculosis-exposed, HIV-1-positive but persistently TB, tuberculin and IGRA negative persons with M. tuberculosis specific antibodies in Cape Town, South Africa.
Kroon EE; Kinnear CJ; Orlova M; Fischinger S; Shin S; Boolay S; Walzl G; Jacobs A; Wilkinson RJ; Alter G; Schurr E; Hoal EG; Möller M
EBioMedicine; 2020 Nov; 61():103053. PubMed ID: 33038764
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma release assay versus tuberculin skin test for latent tuberculosis infection among HIV patients in Brazil.
Kussen GM; Dalla-Costa LM; Rossoni A; Raboni SM
Braz J Infect Dis; 2016; 20(1):69-75. PubMed ID: 26706018
[TBL] [Abstract][Full Text] [Related]
16. Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.
O'Shea MK; Fletcher TE; Beeching NJ; Dedicoat M; Spence D; McShane H; Cunningham AF; Wilson D
PLoS One; 2014; 9(5):e97366. PubMed ID: 24816576
[TBL] [Abstract][Full Text] [Related]
17. Latent tuberculosis infection--Revisiting and revising concepts.
Salgame P; Geadas C; Collins L; Jones-López E; Ellner JJ
Tuberculosis (Edinb); 2015 Jul; 95(4):373-84. PubMed ID: 26038289
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
[TBL] [Abstract][Full Text] [Related]
19. How to use: interferon γ release assays for tuberculosis.
Pollock L; Basu Roy R; Kampmann B
Arch Dis Child Educ Pract Ed; 2013 Jun; 98(3):99-105. PubMed ID: 23580543
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the QuantiFERON®-TB Gold In-Tube Assay and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in an Iranian Referral Hospital.
Pourakbari B; Yousefi K; Mahmoudi S; Sadeghi RH; Mamishi S
Infect Disord Drug Targets; 2019; 19(2):141-144. PubMed ID: 29493468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
